Google
Trusted Resources: Community Center
Online support, community stories, financial assistance
Adam Gardiner Fund Incorporation Blog
The Adam Gardiner Fund Incorporation (AGF) raises money to support the Westmead Amyloidosis Centre in the treatment of amyloidosis, a group of diseases that cause a buildup of abnormal protein in tissues and bodily organs. The Fund also supports clinical research and aims to raise awareness for these life-threatening diseases.
The Adam Gardiner Fund’s mission is to raise funds & awareness for amyloidosis while working within the structure of Westmead Hospitals Immunology Department and its Institute for Immunology & Allergy Research (IIAR).
myBinderRelated Content
-
Joanne Wood Scholarship FundThe Joanne Wood Scholarship Fund is a ch...
-
Q&A Discussion Panel With Drs. Gertz, D’Souza, Rosenbaum & Chakraborty – ASG Webinar – 3...https://www.youtube.com/watch?v=vP4wvJq5...
-
Scott C Feitell, DODr. Feitell specializes in Advanced Hear...
-
Marked Progress in AL Amyloidosis Survival: A 40-Year Longitudinal Natural History StudyThe recent decades have ushered in consi...
-
The Coverage Battle Continues for Veterans With Transthyretin AmyloidosisThe Veterans Health Administration exist...
-
Q&A Session 2 – ASG Webinar 13/13https://www.youtube.com/watch?v=NrEjyVeJ...
-
Prevalence, Severity, and Prognostic Value of Sleep Apnea Syndromes in Cardiac AmyloidosisStudy Objectives: To assess prevalence,...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
